Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02795299
Recruitment Status : Withdrawn (Study not started due to Sponsor decision to not move forward with compound.)
First Posted : June 10, 2016
Last Update Posted : July 11, 2018
Sponsor:
Collaborators:
Techtrials Pesquisa e Tecnologia Ltda
Pharmagenix
Information provided by (Responsible Party):
Bird Rock Bio, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : May 2019
Estimated Study Completion Date : September 2019